| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_203bed9f5c9d709f7123f0f68fdee462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5c79d29e2e9365bb116236db0219a3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe1e24f8daabb87268c95095a9a2afc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_087a60c065d359d762509be2f31a6a14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d12fcf94a35348198bf31558dcff2cf6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y201-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6802 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate |
2012-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d4e06e125926f0a750a3817b8a89908
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9428d55d100c1a60ab827b77a0f4282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ab73778c606b328e5e4806aabfba21d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51684780bd36dbab69653fd2bcae1546 |
| publicationDate |
2014-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014234827-A1 |
| titleOfInvention |
SSAT mRNA TRANSLATION REPRESSION AND ACTIVATION |
| abstract |
The invention provides an isolated nucleic acid having a sequence encoding a spermidine/spermine acetyltransferase (“SSAT”), wherein translation of an mRNA comprising the encoded SSAT has increased basal translation and increased stimulated translation, compared to a wild-type mRNA encoding SSAT. Methods of use for the nucleic acid are also provided. Methods and compositions are also provided for reducing ischemia-reperfusion injury in organs or tissue for transplantation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113817778-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015100312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3639828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4082550-A1 |
| priorityDate |
2011-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |